In last trading session, Oragenics Inc (AMEX:OGEN) saw 5.37 million shares changing hands with its beta currently measuring 0.43. Company’s recent per share price level of $0.38 trading at $0.06 or 15.69% at ring of the bell on the day assigns it a market valuation of $4.59M. That closing price of OGEN’s stock is at a discount of -1936.84% from its 52-week high price of $7.74 and is indicating a premium of 34.21% from its 52-week low price of $0.25. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 2.25 million shares which gives us an average trading volume of 687.09K if we extend that period to 3-months.

Oragenics Inc (AMEX:OGEN) trade information

Upright in the green during last session for gaining 15.69%, in the last five days OGEN remained trading in the green while hitting it’s week-highest on Thursday, 12/19/24 when the stock touched $0.38 price level, adding 15.18% to its value on the day. Oragenics Inc’s shares saw a change of -93.32% in year-to-date performance and have moved 15.41% in past 5-day. Oragenics Inc (AMEX:OGEN) showed a performance of 34.29% in past 30-days. Number of shares sold short was 0.19 million shares which calculate 0.43 days to cover the short interests.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 29.34% during past 5 years.

Oragenics Inc (AMEX:OGEN)’s Major holders

Insiders are in possession of 25.41% of company’s total shares while institution are holding 11.13 percent of that, with stock having share float percentage of 14.92%. Investors also watch the number of corporate investors in a company very closely, which is 11.13% institutions for Oragenics Inc that are currently holding shares of the company.